SLN - Bathi sadurunge bunga, pajak, lan amortisasi Silence Therapeutics PLC
Silence Therapeutics is implementing toxic substance filtration to comply with ESG standards. The EBITDA financial metric serves as a daily scanner of cash health, and its value is currently fixed at 0.00. Partnerships with pharma behemoths ensure a steady inflow of funds, although geopolitical tensions and patent risks create uncertainty regarding the company's intellectual property protection.
Silence Therapeutics plc (SLN) - rincian metrik lan laporan keuangan
- kuotasi saiki lan rata-rata prakiraan nilai:
- statistik kapitalisasi pasar:
- data kapitalisasi buku:
- indikator total utang lan likuiditas perusahaan:
Rasio Kabeh Utang marang Dana Pribadi Silence Therapeutics|SLN - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Silence Therapeutics PLC|SLN - Utang perusahaan|Rasio utang marang aset resik Silence Therapeutics|SLN - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Silence Therapeutics|Rasio likuiditas kritis silence-therapeutics.com
- statistik bathi lan rasio pasar:
SLN - Bathi resik|Bathi resik sing dikarepake Silence Therapeutics|SLN - Koefisien rega marang bathi|Pangali Forward P/E silence-therapeutics.com|SLN - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Silence Therapeutics|SLN - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Silence Therapeutics|SLN - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan silence-therapeutics.com|SLN - Wutah bathi saben saham ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Silence Therapeutics
Analisis kabeh metrik perusahaan:Silence Therapeutics Corp
Absolute operating profit measures the actual volume of cash generated by core production, neutralizing timing gaps between quarterly reports. An EBITDA cash flow analysis allows investors to promptly identify financial risks by assessing the monetization efficiency of siRNA drugs developed by Silence Therapeutics (SLN) through strategic partnerships with global pharmaceutical behemoths to accelerate the market launch of innovations.
Karo sapa Silence Therapeutics saingan
TEM - Bathi operasional sadurunge ngurangi amortisasi|Qiagen N.V. - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi ionispharma.com|RGEN (Repligen) - Bathi operasional sadurunge ngurangi amortisasi|Avidity Biosciences Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi CRSP|WGS (GeneDx Corp) - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi operasional EBITDA RARE|BEAM (beamtx.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA SRPT (Sarepta)|Twist Bioscience Inc (TWST) - Bathi sadurunge bunga, pajak, lan amortisasi|TXG - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi NTLA (Intellia Corp)|STOK: Bathi operasional EBITDA|biolifesolutions.com (BLFS) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Wave Life Sciences Ltd.|Maze Therapeutics, Inc. - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi operasional EBITDA SION|PRME - Bathi sadurunge bunga, pajak, lan amortisasi|Taysha Gene Therapies - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA uniqure.com QURE|MGTX: Bathi operasional sadurunge ngurangi amortisasi|REGENXBIO Inc - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|SLDB: Bathi operasional EBITDA|OCGN - Pendapatan operasional sadurunge ngurangi amortisasi|PACB (Pacific Biosciences) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi benitec.com (BNTC)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Design Therapeutics, Inc. (DSGN)|Pendapatan operasional sadurunge ngurangi amortisasi Rocket Pharma|Bathi sadurunge mbayar bunga, pajak, lan amortisasi 4D Molecular Therapeutics Inc FDMT|Pendapatan operasional sadurunge ngurangi amortisasi Lexeo Therapeutics Inc. (LXEO)|KRRO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|EDIT: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|proqr.com (PRQR) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge amortisasi CDXS|SGMO (Sangamo) - Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi NAUT (Nautilus Biotechnology Inc)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Metagenomi, Inc. (MGX)|precisionbiosciences.com - Bathi operasional sadurunge amortisasi|Bathi operasional EBITDA GBIO (Generation Bio)|Bathi operasional EBITDA Boundless Bio Inc. BOLD|XCUR - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi Imunon, Inc. IMNN|PHIO: Bathi operasional EBITDA|MBIO - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi TransCode Therapeutics Inc.|Bathi sadurunge mbayar bunga, pajak, lan amortisasi BNGO|Bathi operasional EBITDA APDN|BLUE - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi ImmunoPrecise Antibodies Ltd. IPA|OMGA: Bathi operasional sadurunge amortisasi|Singular Genomics - Bathi operasional EBITDA|Regulus Therapeutics, Inc. (RGLS) - Bathi operasional sadurunge ngurangi amortisasi|SYRS: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Telesis Bio, Inc (TBIO)|Bathi operasional sadurunge ngurangi amortisasi TCON|UBX: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi
